Dr. Marc David Polimeni, MD

Dr. Polimeni practices at Excelcare Medical Associates, PA in Hackensack, New Jersey.

Dr. Polimeni's NPI, 1861458499, was assigned on April 22, 2006. Dr. Polimeni holds New Jersey license 25MA05504100.

Dr. Polimeni's primary practice is Excelcare Medical Associates, PA, at 3 University Plz, Hackensack, NJ 07601 in Bergen County. The practice phone is (201) 833-3000.

Dr. Polimeni's primary practice is Excelcare Medical Associates, PA in Hackensack, New Jersey. Dr. Polimeni is also affiliated with Hackensack University Medical Center. The medical group on file is Excelcare Medical Associates. Dmand AI also links Dr. Polimeni to 1 more hospital, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Polimeni practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Polimeni's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Polimeni is licensed in New Jersey.

CMS data shows 2,154 Medicare services from Dr. Polimeni across 13 procedure codes in 2024, for 384 Medicare patients. Medicare paid $148,704 for them. Every service was in an office.

CMS counts 384 Medicare patients who saw Dr. Polimeni in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Polimeni's median patient age at 63, with 39% women.

In 2024, Dr. Polimeni wrote 4,948 Medicare Part D claims for 467 patients. 90% of them were for generic drugs. CMS names the drug for 4,352 of them, across 78 drugs with 11 or more claims each, at $252,167 in total drug cost. In 2023, CMS named 4,103 claims across 74 drugs.

Dr. Polimeni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Polimeni as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 525 general payments to Dr. Polimeni from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $1,960.